Who has invested in R3 Vascular?

Deerfield Management are named among the investors backing R3 Vascular.

R3 Vascular Funding: $87M Raised, Series B (2024)

R3 Vascular funding overview

R3 Vascular is based in Mountain View, California. R3 Vascular has raised $87M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2024. The round record for R3 Vascular runs through 2024; nothing later has been disclosed. Investors on record include Deerfield Management.

R3 Vascular at a glance

Total raised: $87M
Latest round: Series B
Latest round date: January 2024
Headquarters: Mountain View, California
Notable investors: Deerfield Management

Frequently asked about R3 Vascular funding

How much has R3 Vascular raised?: R3 Vascular has raised $87M in total disclosed funding across the rounds on record.
Who has invested in R3 Vascular?: Deerfield Management are named among the investors backing R3 Vascular.
What was the latest R3 Vascular funding round?: The most recent disclosed round is a Series B, announced in January 2024.
Where is R3 Vascular based?: R3 Vascular is based in Mountain View, California.
When did R3 Vascular last raise?: The last disclosed R3 Vascular round closed in January 2024 at Series B.

R3 Vascular totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Mountain View below to benchmark round size and investor mix.

R3 Vascular Funding: $87M Raised, Series B (2024)

R3 Vascular funding overview

R3 Vascular at a glance

Frequently asked about R3 Vascular funding

Companies related to R3 Vascular (36)

Browse related funding lists (4)